The pattern no single source sees

Search

Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.

Company or person19

ADMA BIOLOGICS, INC.

Company

4 records in the corpus

HCW Biologics Inc.

Company

10 records in the corpus

AbCellera Biologics Inc.

Company

9 records in the corpus

Theriva Biologics, Inc.

Company

3 records in the corpus

FibroBiologics, Inc.

Company

6 records in the corpus

Adicet Bio, Inc.

Company

9 records in the corpus

Bone Biologics Corp

Company

8 records in the corpus

Beta Bionics, Inc.

Company

21 records in the corpus

ADAPTIN BIO, INC.

Company

2 records in the corpus

BIOLARGO, INC.

Company

9 records in the corpus

BiomX Inc.

Company

23 records in the corpus

PUMA BIOTECHNOLOGY, INC.

Company

2 records in the corpus

AEON Biopharma, Inc.

Company

7 records in the corpus

ABVC BIOPHARMA, INC.

Company

8 records in the corpus

AYTU BIOPHARMA, INC

Company

3 records in the corpus

Advanced Biomed Inc.

Company

5 records in the corpus

20/20 Biolabs, Inc.

Company

7 records in the corpus

BIOVIE INC.

Company

13 records in the corpus

BIOGEN INC.

Company

4 records in the corpus

Primary record4

ADMA BIOLOGICS, INC. filed 4

SEC form 4 filed by ADMA BIOLOGICS, INC. (CIK 1368514) on 2026-11-05.

05 Nov 2026 · sec daily index

ADMA BIOLOGICS, INC. filed 8-K

Item 2.02 Results of Operations and Financial Condition. On November 4, 2026, ADMA Biologics, Inc. issued a press release announcing its financial results for the three months ended September 30, 2026, and providing a bu

04 Nov 2026 · sec daily index

ADMA BIOLOGICS, INC. filed SCHEDULE 13G

0000093751-26-000402.txt : 20260807 SCHEDULE 13G 1 primary_doc.xml X0202 SCHEDULE 13G 0000093751 XXXXXXXX LIVE COMMON STOCK 06/30/2026 0001368514 ADMA BIOLOGICS INC 000899104 465 ROUTE 17 SOUTH RAMSEY NJ 07446 Rule 13d-1

07 Aug 2026 · sec daily index

ADMA BIOLOGICS, INC. filed 8-K

Item 2.02 Results of Operations and Financial Condition. On August 5, 2026, ADMA Biologics, Inc. issued a press release announcing its financial results for the three months ended June 30, 2026, and providing a business

05 Aug 2026 · sec daily index